Issue Contents:  Aug 2, 2010

• FDA Lifts Hold on Geron Stem Cell Trial, Shares Leap
• Solid Earnings for Amgen, but Denosumab Still Center Stage
• Senate Panel Approves Pay-for-Delay Measure
• Pfizer Selling Idun to Conatus; Liver-Disease 'Homecoming'
• Orexigen's Contrave Remains Hardy in Ongoing Obesity War
• Appointments And Advancements
• Stock Movers
• Other News To Note
• Bench Press

      The above issue is also available as one PDF File